Charcot-Marie-Tooth disease axonal type 2V (CMT2V) is a very rare inherited nerve disease. It damages the peripheral nerves, which are the long nerves that carry signals between the brain/spinal cord and the arms, legs, hands, and feet. In CMT2V, the axons (the long “wire” part of the nerve) are mainly affected, not the myelin covering. Muscular Dystrophy Association+1
Charcot-Marie-Tooth disease axonal type 2V (CMT2V) is a rare, inherited nerve disease that mainly damages the long nerves to the legs and arms. It is “axonal,” which means the inner part of the nerve fibre (the axon) is affected rather than the myelin covering. People often develop burning or aching pain in the legs, cramps, tingling, numbness, poor balance, and reduced reflexes. Symptoms may start from adolescence to older adult life and slowly get worse over many years. Genetic Diseases Center+1
CMT2V usually starts in adulthood. People often first notice recurrent leg pain, sometimes with cramps. Over time this pain can become constant and may feel like burning, tingling, or “pins and needles” in the feet and later in the hands. It is a hereditary motor and sensory neuropathy, which means it affects both movement (motor) and feeling (sensory). Genetic Diseases Center+1
This condition is autosomal dominant. That means a person usually needs only one copy of the changed gene from one parent to develop the disease. Each child of an affected parent has a 50% chance of inheriting the faulty gene. Genetic Diseases Center+1
Other names
CMT2V has many other names in the medical literature. These names all describe the same disease or very closely related descriptions: Genetic Diseases Center+1
-
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2V
-
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to NAGLU mutation
-
Charcot-Marie-Tooth neuropathy type 2V
-
Charcot-Marie-Tooth disease caused by mutation in NAGLU
-
CMT2V
-
Hereditary adult-onset painful axonal polyneuropathy
These names tell us that the disease is inherited, affects the axons of the nerves, often begins in adult life, and causes painful neuropathy in the legs and later in the hands. Genetic Diseases Center+1
Types of Charcot-Marie-Tooth disease and where CMT2V
Charcot-Marie-Tooth (CMT) disease is not one single disorder. It is a large group of genetic nerve diseases. Doctors divide CMT into main types based on how the nerve is damaged and how it is inherited: Wikipedia+1
-
CMT1 – demyelinating type
-
The myelin (insulating coat around the nerve) is mainly damaged.
-
Nerve conduction speed is slow.
-
-
CMT2 – axonal type
-
The axon (the core “wire” of the nerve) is mainly damaged.
-
Nerve conduction speed is often near normal, but the signal strength (amplitude) is reduced.
-
-
Intermediate CMT
-
Has features between CMT1 and CMT2 on nerve tests.
-
-
CMTX
-
X-linked form of CMT (gene on the X chromosome).
-
-
CMT4 and other rare forms
-
Usually recessive and often more severe or earlier onset.
-
Within CMT2, there are many numbered subtypes such as CMT2A, 2B, 2D, 2V, and others. Each subtype is defined by its causative gene. CMT2V is the subtype where the disease is linked to a harmful change (mutation) in the NAGLU gene. National Organization for Rare Disorders+1
Causes
Medically, CMT2V has one true root cause: a disease-causing change in the NAGLU gene. The 20 points below describe this cause, the different ways it appears, and related mechanisms and risk factors that influence the disease course. National Organization for Rare Disorders+2Genetic Diseases Center+2
-
Pathogenic mutation in the NAGLU gene
The NAGLU gene gives instructions to make an enzyme called alpha-N-acetylglucosaminidase, which works inside lysosomes (the “recycling centers” of cells). A harmful mutation changes this enzyme, and this change is considered the main cause of CMT2V. MedlinePlus+1 -
Autosomal dominant inheritance
In most people with CMT2V, the faulty NAGLU gene is inherited from an affected parent. Because the disease is autosomal dominant, one changed copy of the gene is enough to cause symptoms. Each child has a 50% chance of inheriting it. Genetic Diseases Center+1 -
De novo (new) NAGLU mutation
Sometimes, the NAGLU mutation happens for the first time in the egg or sperm or early embryo. In these cases, the parents do not have CMT2V, but the child is affected because of this new mutation. GARD explains that genetic mutations can be hereditary or can occur when cells divide. Genetic Diseases Center -
Reduced or altered NAGLU enzyme activity
The NAGLU enzyme helps break down certain complex sugars (glycosaminoglycans, especially heparan sulfate) in lysosomes. When the gene is mutated, the enzyme may be less active or work abnormally. This can disturb normal cell function in peripheral nerves. MedlinePlus+1 -
Lysosomal dysfunction in nerve cells
Faulty NAGLU enzyme activity can lead to lysosomal stress and accumulation of partially broken-down molecules. Over time this may harm peripheral nerve cells, especially the long sensory and motor axons, contributing to neuropathy. MedlinePlus+1 -
Selective vulnerability of long peripheral axons
The longest nerves, such as those going to the feet, are more fragile because they must transport materials over very long distances. Any disturbance in cell recycling or metabolism, including NAGLU-related problems, tends to damage these long axons first, leading to leg pain and sensory loss. Muscular Dystrophy Association+1 -
Family history of CMT or painful neuropathy
Having a family history of CMT-like symptoms is a key clue that the NAGLU mutation runs in the family. The family history does not cause the disease by itself, but it reflects the presence of the same inherited gene change. Genetic Diseases Center+1 -
Random DNA copying errors
During cell division, DNA can sometimes be copied with small mistakes. GARD notes that such random errors can produce genetic mutations that later cause diseases like CMT2V, even when there is no clear family history. Genetic Diseases Center -
Possible contribution of environmental mutagens
GARD explains that UV radiation or certain environmental factors can contribute to genetic mutations in general. For CMT2V, such factors do not cause symptoms directly, but they might play a role in how the original NAGLU mutation arose in an ancestor or in a de novo case. Genetic Diseases Center -
Age-related stress on peripheral nerves
CMT2V often begins in adulthood, when nerves have already experienced years of wear and tear. The presence of a NAGLU mutation may make these nerves less able to handle normal aging, so symptoms appear later in life. Genetic Diseases Center+1 -
Interaction with other genetic variants
A person with CMT2V may also carry other genetic variants that affect nerve health, inflammation, or pain sensitivity. These additional variants do not cause CMT2V alone but can influence how severe the NAGLU-related neuropathy becomes. -
Mitochondrial stress in peripheral nerves
Peripheral nerves need a lot of energy. Lysosomal problems can indirectly stress mitochondria (the “power plants” of the cell). In many CMT types, mitochondrial stress contributes to axonal degeneration; this likely plays some role in CMT2V as well. Wikipedia+1 -
Chronic low-grade inflammation around nerves
Abnormal storage of substances inside cells can activate immune pathways. Low-grade inflammation can further damage nerve fibers, worsening the neuropathy over time. -
Secondary damage to myelin
Although CMT2V is mainly an axonal neuropathy, damage to axons can secondarily affect the myelin produced by Schwann cells. This secondary myelin damage can further slow or block nerve signals and aggravate symptoms. Muscular Dystrophy Association+1 -
Mechanical stress on weak nerves
When leg muscles become weak, walking patterns change. Abnormal gait can increase physical stress on already fragile nerves and muscles, contributing to further nerve irritation and pain. -
Poor nerve regeneration capacity
Human peripheral nerves can regenerate only slowly and imperfectly. In CMT2V, persistent genetic damage means that any small injury to a nerve fiber is less likely to heal fully, which contributes to progressive symptoms. Muscular Dystrophy Association+1 -
Sleep disturbance and pain amplification
Many patients have sleep abnormalities because of pain and tingling. Poor sleep does not cause CMT2V, but it can amplify pain perception and fatigue, making the neuropathy feel worse and harder to manage. Genetic Diseases Center+1 -
Co-existing health problems
Conditions such as diabetes, vitamin deficiencies, or kidney disease can cause separate nerve damage. In a person with CMT2V, these extra problems can make neuropathy more severe, although they are not the primary cause. -
Medication-related nerve stress
Some drugs (for example certain chemotherapy agents) can damage nerves. In someone with CMT2V, whose nerves are already fragile, these medicines can have a stronger negative effect and worsen symptoms. -
Lifestyle factors (smoking, chronic alcohol use)
Smoking and long-term heavy alcohol use can harm blood vessels and nerves. These habits do not cause the NAGLU mutation, but they can speed up nerve damage and symptom progression in people who already have CMT2V.
Symptoms
The symptom pattern of CMT2V is shaped by axonal damage to long sensory and motor nerves in the legs and later in the hands. Genetic Diseases Center+2Global Genes+2
-
Recurrent leg pain
People often feel deep aching, burning, or throbbing pain in the legs. At first this may come and go, especially after standing or walking. Over time it can become constant and may disturb daily activities and sleep. Genetic Diseases Center+1 -
Painful cramps in the legs
Some people have sudden, tight muscle cramps in the calves or feet. These cramps are often worse at night or after long periods of walking. They are caused by irritated and unstable motor nerves. Global Genes+1 -
Lower limb paresthesias (tingling and “pins and needles”)
Many patients describe tingling, buzzing, or “pins and needles” in the feet and lower legs. This happens because damaged sensory nerves send abnormal signals to the brain. Genetic Diseases Center+1 -
Distal sensory impairment (reduced feeling in feet and hands)
Over time, the ability to feel light touch, temperature, or pain in the feet can decrease. Later, the same may happen in the hands. This pattern, starting distally (far from the body) and moving upward, is typical for length-dependent neuropathy. Genetic Diseases Center+1 -
Impaired vibration sense
When the doctor uses a vibrating tuning fork on the ankles or toes, people with CMT2V often cannot feel it well. This shows loss of large-fiber sensory function, which is important for balance and joint position. Genetic Diseases Center+1 -
Hyporeflexia (reduced deep tendon reflexes)
Reflexes such as the knee-jerk and ankle reflex become weak or absent. This happens because the reflex arc needs healthy sensory and motor nerves, which are damaged in CMT2V. Genetic Diseases Center+1 -
Mild sensory ataxia (unsteady balance)
Some patients develop unsteady walking, especially in the dark or with eyes closed. Because the brain gets less accurate information from the feet, it becomes harder to know where the legs are in space, leading to a “wobbly” gait. Genetic Diseases Center+1 -
Peripheral neuropathy signs in examination
Doctors often find a combination of reduced feeling, weakness, and reflex loss in the feet and legs. This pattern is typical of peripheral neuropathy and helps distinguish CMT2V from problems in the brain or spinal cord. Genetic Diseases Center+1 -
Progressive extension to the hands
As the disease advances, tingling, numbness, and sometimes pain can spread from the feet upward and later appear in the hands and fingers. This can make fine tasks such as buttoning clothes or writing more difficult. Genetic Diseases Center+1 -
Sleep disturbances
Because of pain, burning sensations, or leg cramps, many people with CMT2V have trouble falling or staying asleep. Poor sleep then worsens daytime fatigue and can increase the sense of pain. Genetic Diseases Center+1 -
Fatigue and reduced stamina
Walking with weak and painful legs requires extra effort. Over time, people may feel tired more easily and may have to rest more often, especially after standing or walking for long periods. -
Difficulty walking on uneven ground
Reduced vibration sense and mild sensory ataxia make it hard to walk on rough surfaces or in the dark. People may feel insecure, need to look carefully at their feet, or use rails or walking aids for safety. Genetic Diseases Center+1 -
Occasional foot deformities (in some patients)
In general CMT, high arches or hammertoes are common. In CMT2V, some patients may also develop mild foot shape changes due to imbalance between weak and relatively stronger muscles. Wikipedia+1 -
Numbness or “walking on cotton” feeling
Some people describe a sensation like walking on thick socks or cotton. This comes from loss of touch and position sense in the soles of the feet. -
Emotional impact (anxiety or low mood)
Chronic pain, sleep problems, and uncertainty about the future can lead to feelings of worry, frustration, or sadness. While this does not cause CMT2V, mental health is an important part of the overall symptom burden.
Diagnostic tests
Diagnosing CMT2V usually needs a combination of clinical examination, nerve tests, and genetic tests. The goal is to show that there is a hereditary axonal neuropathy and to confirm the NAGLU mutation. Muscular Dystrophy Association+2Wikipedia+2
Physical exam tests
-
Detailed medical history and general physical exam
The doctor asks about symptoms (pain, tingling, weakness, sleep problems), age at onset, and family history. A general exam checks overall health and rules out other causes such as diabetes, thyroid disease, or vitamin deficiency. Genetic Diseases Center+1 -
Neurological examination of strength and tone
The neurologist tests muscle strength in the legs and arms, looks for wasting of muscles, and checks for any abnormal stiffness. In CMT2V, there may be mild distal weakness, although pain and sensory problems are often more prominent. Muscular Dystrophy Association+1 -
Gait observation
The doctor watches how the person walks: step height, stride length, and balance. In CMT2V, gait may show cautious steps, avoidance of pressure because of pain, or mild unsteadiness due to sensory ataxia. Genetic Diseases Center+1 -
Inspection of feet and hands
The examiner looks for high arches, hammertoes, calluses, or muscle wasting in the feet and lower legs. In the hands, they look for thinning of small muscles between the fingers. These findings support a chronic peripheral neuropathy like CMT. Wikipedia+1
Manual bedside tests
-
Manual muscle testing (MMT)
The doctor asks the person to push or pull against resistance at the ankles, toes, knees, and hands. Grading muscle strength helps show which muscles are weak and whether weakness is mainly distal, as in CMT. Muscular Dystrophy Association+1 -
Deep tendon reflex testing
Using a reflex hammer, the doctor checks knee and ankle reflexes. In CMT2V, these reflexes are often reduced or absent (hyporeflexia), fitting with the pattern of a length-dependent neuropathy. Genetic Diseases Center+1 -
Romberg balance test
The patient stands with feet together, first with eyes open, then closed. If balance worsens markedly with eyes closed, this suggests sensory ataxia from impaired position sense in the feet, which can occur in CMT2V. Genetic Diseases Center+1 -
Tandem (heel-to-toe) walking test
Walking in a straight line with heel touching toe is more difficult when sensory feedback is poor. Trouble performing this test supports the presence of sensory ataxia and neuropathy. -
Manual sensory testing with light touch and pinprick
The doctor uses a cotton wisp and a blunt pin to test feeling in the feet, legs, hands, and arms. Reduced or altered sensation in a stocking-and-glove pattern suggests a peripheral neuropathy like CMT2V. Genetic Diseases Center+1 -
Vibration sense testing with a tuning fork
A vibrating tuning fork (commonly at 128 Hz) is placed on bony points at the toes and ankles. People with CMT2V often feel the vibration less or lose it early, which matches the impaired vibratory sensation listed among key symptoms. Genetic Diseases Center+1
Lab and pathological tests
-
Genetic testing for NAGLU mutation
A blood sample is used to sequence genes known to cause CMT. In CMT2V, testing identifies a pathogenic variant in the NAGLU gene, confirming the diagnosis at the DNA level. Genetic testing also helps with family counseling and future planning. National Organization for Rare Disorders+2MedlinePlus+2 -
Targeted CMT gene panel or whole-exome sequencing
In some cases, doctors order a broader panel covering many CMT-related genes or whole-exome sequencing. This approach is useful when the specific subtype is not clear and helps distinguish CMT2V from other inherited neuropathies. Wikipedia+1 -
Enzyme activity assay for alpha-N-acetylglucosaminidase (research/selected centers)
Specialized laboratories can measure NAGLU enzyme activity in blood cells or fibroblasts. Markedly abnormal results support the role of NAGLU dysfunction in the disease, although this test is not routinely available everywhere. MedlinePlus+1 -
Routine blood tests to rule out other neuropathy causes
Tests such as fasting glucose, HbA1c, vitamin B12, thyroid function, kidney and liver tests are used to exclude common acquired causes of neuropathy. Normal results make a hereditary cause like CMT2V more likely. Wikipedia+1 -
Nerve biopsy (rarely needed now)
In selected or unclear cases, a small sample of a sensory nerve (often from the leg) may be examined under the microscope. In axonal CMT, biopsy may show loss of axons with relatively preserved myelin. Today, genetic testing usually replaces this invasive test. Muscular Dystrophy Association+1
Electrodiagnostic tests
-
Nerve conduction studies (NCS)
Electrodes placed on the skin deliver small electrical pulses to nerves. In CMT2V, nerve conduction velocity may be normal or only slightly reduced, but the response size (amplitude) is lower, showing axonal loss rather than primary myelin damage. Muscular Dystrophy Association+2Wikipedia+2 -
Electromyography (EMG)
A fine needle electrode is inserted into muscles to record their electrical activity. EMG can show signs of chronic denervation and re-innervation, confirming that muscles are suffering from long-standing nerve damage. Muscular Dystrophy Association+1 -
Quantitative sensory testing (QST)
QST uses controlled mechanical or thermal stimuli to measure thresholds for detecting vibration, warm, and cold sensations. In CMT2V, thresholds are often raised, especially in the feet, reflecting large-fiber and sometimes small-fiber sensory involvement. -
Somatosensory evoked potentials (SSEPs)
SSEPs measure the brain’s response to repeated stimulation of peripheral nerves. Delayed or reduced responses can show disrupted signal transmission in sensory pathways, supporting the diagnosis of a peripheral neuropathy.
Imaging tests
-
MRI or ultrasound to exclude other causes of symptoms
MRI of the spine can rule out spinal cord compression or other central nervous system problems that might mimic neuropathy. In some centers, ultrasound or MRI of peripheral nerves and muscles can show nerve thinning or muscle atrophy, supporting the clinical impression of CMT. Wikipedia+1
Non-pharmacological treatments (therapies and others)
(All of these are supportive. They must be planned and supervised by health-care professionals.)
-
Physiotherapy (physical therapy)
Physiotherapy uses gentle movement, stretching and strengthening exercises to keep muscles as strong and flexible as possible. In CMT2V it can slow down stiffness, reduce risk of contractures (shortened muscles), and help balance and walking. The therapist often teaches a home program with low-impact exercise such as stretching, cycling, or swimming. Regular sessions, started early and continued for life, can greatly improve comfort and independence. nhs.uk+2Physiopedia+2 -
Occupational therapy
Occupational therapists focus on daily activities such as dressing, writing, using a phone and cooking. In CMT2V they assess hand weakness, poor grip and fatigue, then suggest aids such as adapted cutlery, pens, keyboard supports and bathroom equipment. They also teach energy-saving methods, splitting tasks into shorter steps and planning rest breaks. This support can reduce frustration and helps people remain active at work, at school and at home. Muscular Dystrophy Association+1 -
Strengthening exercises
Targeted strengthening exercises aim to keep “spared” muscles working for as long as possible. These usually use light resistance bands or small weights, and focus on hips, thighs, shoulders and core, which can compensate for weak ankles and hands. Exercises must be gentle and regular, not heavy or sudden, to avoid over-work damage to fragile nerves and muscles. A therapist adjusts the program over time and watches for pain or new weakness. Physiopedia+2ScienceDirect+2 -
Stretching and range-of-motion therapy
Tight calf and foot muscles are common in CMT2V and can lead to contractures and fixed deformities. Daily stretching of calves, hamstrings, hips and fingers keeps joints moving and makes braces and shoes more comfortable. Passive stretching (by the therapist or a helper) and active stretching (by the patient) are both useful. Gentle, regular stretching is safer and more effective than forceful, quick stretches. nhs.uk+1 -
Aerobic / cardiovascular exercise
Low-impact aerobic exercise such as walking in a pool, cycling on a stationary bike or swimming helps lung and heart health, controls weight and improves mood and sleep. For CMT2V, exercises are chosen to avoid falls, foot strain and fatigue. Short, frequent sessions are often better than long, intense workouts. A physiotherapist or doctor checks heart and lung status before starting a new program. Physiopedia+2PMC+2 -
Ankle–foot orthoses (AFOs)
AFOs are custom braces for the ankle and foot. In CMT2V they are often used for foot drop, ankle instability and high-arched feet. AFOs hold the foot in a safer position for walking, reduce tripping, and decrease tiredness. Modern AFOs are light and can be worn inside many shoes. Correct fitting and regular review are important, because poor-fitting braces can cause skin sores. Charcot-Marie-Tooth Association+2Mayo Clinic+2 -
Supportive shoes and orthotic insoles
High-top shoes, boots and custom insoles help support weak ankles and abnormal arches. Soft padding and wide toe boxes reduce pressure points and protect numb areas from blisters and ulcers. Foot specialists (podiatrists) and orthotists can design insoles to improve weight distribution and balance. Good footwear may delay or reduce the need for surgery. Mayo Clinic+2Charcot-Marie-Tooth Association+2 -
Hand splints and wrist supports
Weak hand and finger muscles can make it hard to grip or write. Thumb and wrist splints hold joints in a better position and increase pinch strength, which protects joints from strain. Splints are often used only during specific activities, such as typing, and removed at rest. An occupational therapist decides the best design and teaches safe use and skin care. Mayo Clinic+1 -
Balance and gait training
Balance training uses simple tasks such as standing with feet together, stepping in different directions, and practising safe turning. Gait training looks closely at how a person walks and then uses cues, metronome beats, treadmill practice or visual markers on the floor to improve pattern and safety. This focus can reduce falls and increase confidence in crowded or dark places. Physiopedia+2PMC+2 -
Pain management with physical methods
Non-drug pain methods include heat packs, cold packs, massage, gentle mobilization and sometimes transcutaneous electrical nerve stimulation (TENS). These can reduce muscle spasm, burning neuropathic pain and cramps, especially when combined with exercise and relaxation. A therapist teaches safe use, correct temperature, and how often to apply each method. ScienceDirect+2PMC+2 -
Podiatry and regular foot care
Because sensation is reduced, small wounds on the feet can be missed and turn into ulcers. Regular podiatry can remove hard skin, trim nails safely and check for pressure areas. Patients are taught to inspect feet daily, keep skin moisturized and avoid walking barefoot. Early care of small problems helps prevent infections and serious deformities. nhs.uk+2ScienceDirect+2 -
Sleep hygiene and rest planning
Pain, cramps and tingling can disturb sleep in CMT2V. Simple rules such as a regular sleep time, a dark and quiet room, avoiding screens and heavy meals before bed, and using relaxation exercises can help. Planning daytime rests and pacing activities can also reduce evening pain and insomnia. Good sleep supports mood, energy and coping. Genetic Diseases Center+1 -
Psychological support and counselling
Living with a chronic, inherited condition can cause fear, sadness, or anger. Psychological support from a counsellor or psychologist helps people learn coping skills, manage anxiety or depression, and talk about family and genetic issues. Support groups, online communities and patient organizations for CMT also offer shared experience and practical advice. Genetic Diseases Center+2PMC+2 -
Education and self-management training
Understanding CMT2V helps patients make better choices. Education usually covers disease basics, inheritance, exercise safety, fall prevention, foot care, pain management and work or school adaptations. Simple written plans and checklists help people follow daily routines. Education should also include realistic expectations: treatments aim to slow disability, not cure the disease. Genetic Diseases Center+2Muscular Dystrophy Association+2 -
Workplace and school adaptations
Reasonable adjustments might include ergonomic chairs and desks, voice-to-text software, breaks to stretch, easier access routes, or flexible schedules. Occupational therapists can visit work or school to suggest changes. Early discussion with teachers or employers can prevent accidents, reduce fatigue and support continued study and employment. Genetic Diseases Center+1 -
Assistive devices for mobility
Canes, trekking poles, walkers and wheelchairs are tools to maintain independence, not signs of “failure.” In CMT2V they can reduce falls, increase walking distance and save energy for important activities. Choice of device depends on balance, upper-body strength and home layout. Training ensures safe use on stairs, curbs and uneven ground. Muscular Dystrophy Association+2Medscape eMedicine+2 -
Fall-prevention and home safety modifications
Simple changes such as removing loose rugs, installing grab bars, using non-slip mats, adding night-lights, and organizing often-used items at waist height can greatly reduce falls. A home safety assessment by a therapist can identify hidden risks and prioritize affordable changes. This is especially important when sensation and balance are poor. nhs.uk+1 -
Genetic counselling for patient and family
Genetic counsellors explain inheritance patterns, risks for children and relatives, and options for genetic testing. They help families think about reproductive choices and emotional reactions to a genetic diagnosis. In CMT2V, which is autosomal dominant, counselling is important because each child has a 50% chance of inheriting the mutation. Genetic Diseases Center+2National Organization for Rare Disorders+2 -
Participation in clinical research (when available)
Although there is no proven disease-modifying therapy yet, clinical trials test new drugs and strategies. Joining a study may give access to experimental treatments and extra monitoring, but also carries unknown risks. Patients should talk carefully with their specialist and study team and read consent forms in simple language before deciding. Genetic Diseases Center+3Genetic Diseases Center+3PMC+3 -
Lifestyle counselling (weight control, smoking, alcohol)
Extra body weight increases strain on weak feet and ankles and makes braces and walking harder. Smoking can damage blood vessels and nerves and is strongly discouraged. Heavy alcohol use also harms nerves. A healthy diet, avoiding tobacco, and limiting alcohol can slow additional nerve damage and improve overall health and energy. PMC+1
Drug treatments
Important: These medicines are usually used off-label or for related neuropathic conditions, not specifically approved for CMT2V. Doses below are typical adult ranges from FDA labels or common practice; they are not personal advice. Always follow a neurologist’s prescription. PMC+2ScienceDirect+2
-
Gabapentin (Neurontin and others)
Gabapentin is an anti-seizure drug that also treats neuropathic pain. It reduces abnormal firing in damaged nerves. Doctors often start with a low dose such as 300 mg at night and slowly increase, sometimes up to 1800–3600 mg per day in divided doses, depending on response and kidney function. Common side effects include dizziness, sleepiness and swelling of legs. FDA Access Data+2FDA Access Data+2 -
Pregabalin (Lyrica, Lyrica CR)
Pregabalin is related to gabapentin and is approved for several types of nerve pain. It binds to calcium channels on nerve cells to reduce the release of pain-signalling chemicals. Usual total daily dose ranges from 150–600 mg in divided doses or as an extended-release tablet. Common side effects are dizziness, sleepiness, weight gain and swelling. FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Duloxetine (Cymbalta)
Duloxetine is an antidepressant that is also approved for diabetic neuropathic pain and chronic musculoskeletal pain. It increases serotonin and norepinephrine, which help modulate pain pathways in the brain and spinal cord. Typical doses are 30–60 mg once daily. Side effects may include nausea, dry mouth, sleepiness, sweating and changes in blood pressure. FDA Access Data+2FDA Access Data+2 -
Tricyclic antidepressants (amitriptyline, nortriptyline)
These older antidepressants can be very effective for nerve pain at low doses. They block reuptake of serotonin and norepinephrine and also have actions on sodium channels. Doses for pain are often 10–75 mg at night. Side effects include dry mouth, constipation, blurred vision, weight gain and drowsiness; in overdose they can be dangerous, so careful monitoring is needed. Medscape eMedicine+1 -
Tramadol (Ultram, Conzip and generics)
Tramadol is a weak opioid that also affects serotonin and norepinephrine. It may be used for moderate, short-term neuropathic pain when other options fail. Usual doses vary, for example 50–100 mg every 4–6 hours as needed (with a maximum daily limit), or extended-release forms once daily. Tramadol carries risks of addiction, seizures, respiratory depression and serotonin syndrome, especially with other medicines. FDA Access Data+2FDA Access Data+2 -
Non-steroidal anti-inflammatory drugs (NSAIDs)
Drugs like ibuprofen or naproxen help with muscle and joint pain or cramps but are usually less effective for burning nerve pain. They reduce production of prostaglandins, which are chemicals involved in inflammation and pain. Side effects include stomach upset, ulcers, kidney problems and increased blood pressure, especially with long-term use. Medscape eMedicine+1 -
Topical lidocaine (patches or creams)
Lidocaine patches or gels numb the skin by blocking sodium channels on nerve endings. They may be placed over small areas of very painful skin, such as the top of the foot. They give local relief with fewer body-wide side effects. Skin irritation or redness can occur, and patches must be used according to label instructions. Medscape eMedicine+1 -
Topical capsaicin
Capsaicin cream or high-dose patches reduce pain by depleting substance P, a pain neurotransmitter in nerve endings. After an initial burning sensation, repeated use can decrease local pain over time. Application must be careful, away from eyes and sensitive areas. Burning, redness and temporary increased pain are common at first. Medscape eMedicine+1 -
Dalfampridine (Ampyra)
Dalfampridine is a potassium-channel blocker approved to improve walking in multiple sclerosis. It increases conduction of signals in demyelinated axons. Some specialists have considered it experimentally in other walking disorders, but it is not approved for CMT. Typical MS dose is 10 mg twice daily. It carries a dose-related risk of seizures and is contraindicated in people with significant kidney disease. AmeriHealth+3FDA Access Data+3FDA Access Data+3 -
Short-acting opioids (only in selected cases)
Stronger opioids such as oxycodone or morphine may be used in rare cases of severe, refractory pain when other options fail and after careful assessment. They act on opioid receptors to reduce the perception of pain. Because of high risks of addiction, tolerance, constipation, hormonal changes, falls and overdose, most guidelines avoid or strictly limit opioid use in chronic neuropathic pain. FDA Access Data+2FDA Access Data+2 -
Muscle relaxants for cramps (e.g., baclofen)
Baclofen acts on GABA-B receptors in the spinal cord to reduce muscle spasm. It may help painful cramps or spasticity if present. Doses are increased slowly to avoid drowsiness, weakness and dizziness. Sudden stopping of high doses can cause withdrawal symptoms, so any change must be supervised by a doctor. Medscape eMedicine+1 -
Low-dose benzodiazepines (e.g., clonazepam) for severe cramps
In some cases, very low doses of clonazepam at night are used to ease spasms and help sleep. These drugs enhance GABA, a calming brain chemical. Because they can cause dependence, falls, confusion and memory problems, especially with long-term use, they must be used carefully and usually for short periods. Medscape eMedicine+1 -
Antidepressants for mood and coping (SSRIs, SNRIs)
Living with chronic pain and disability increases the risk of depression and anxiety. Selective serotonin reuptake inhibitors (SSRIs) or SNRIs like duloxetine can treat mood and sometimes also improve pain perception. Doses vary by drug and are taken once or twice daily. Side effects depend on the specific medicine and must be monitored by a doctor. FDA Access Data+2FDA Access Data+2 -
Sleep medicines (short-term)
When pain and tingling severely affect sleep, short-term use of sleep medicines may be considered while non-drug strategies are also used. These might include certain antihistamines or prescription hypnotics. All can cause daytime drowsiness, dependence or falls, so they should be used at the lowest dose and for the shortest time possible. Muscular Dystrophy Association+2Genetic Diseases Center+2 -
Vitamin D supplementation
Vitamin D supports bone health and immune function. Many people with chronic disease or limited outdoor activity are deficient. Doctors may prescribe daily or weekly doses based on blood levels. Correcting deficiency may reduce bone pain and fracture risk but does not directly treat nerve damage. Too much vitamin D can be harmful, so levels should be monitored. PMC+1 -
B-complex vitamins (including B1, B6, B12)
B vitamins are important for nerve metabolism. In people with proven deficiency (such as low B12), replacement can improve neuropathy or prevent worsening. Doses and routes (oral or injection) depend on the degree of deficiency. Giving high doses without deficiency does not cure genetic CMT and, in the case of excess B6, can actually harm nerves. PMC+1 -
Alpha-lipoic acid (in some neuropathies)
Alpha-lipoic acid is an antioxidant sometimes used for diabetic neuropathy. It may reduce oxidative stress in nerves. Evidence in CMT is limited and mixed, and doses vary in studies. Side effects can include nausea and hypoglycaemia in people with diabetes. Any use should be discussed with a doctor who knows the full medicine list. ScienceDirect+1 -
Ascorbic acid (vitamin C) in research settings
High-dose vitamin C was tested in CMT1A because it reduces PMP22 expression in animal models, but human trials did not show meaningful benefit. It is not routinely recommended as a disease-modifying treatment. Normal dietary intake of vitamin C is still important for general health, but very high doses may have side effects such as kidney stones. ResearchGate+3ScienceDirect+3The Lancet+3 -
Experimental disease-modifying drugs (clinical trials)
Several drugs and combinations (for example, PXT3003 for CMT1A) are being studied to change disease progression by altering myelin or axonal biology. These are not yet approved for CMT2V and are only available in clinical trials. Participation should be guided by a specialist familiar with current research. Ovid+3PMC+3ClinicalTrials.gov+3 -
Drugs to treat associated conditions
People with CMT2V may also have diabetes, high blood pressure, high cholesterol or mood disorders. Treating these conditions with appropriate medicines is very important because they can further damage nerves, blood vessels and general health. Drug choices consider possible effects on nerves and the risk of drug–drug interactions. PMC+2ScienceDirect+2
Dietary molecular supplements
Evidence for supplements in CMT2V is limited. They should not replace prescribed treatment. Always talk to a doctor before starting any supplement, especially if you take other medicines. PMC+1
-
Omega-3 fatty acids (fish oil) – may support nerve cell membranes and reduce inflammation.
-
Coenzyme Q10 – part of mitochondrial energy production; sometimes used for fatigue.
-
Alpha-lipoic acid – antioxidant with some data in diabetic neuropathy.
-
Vitamin D – for bone and immune health when deficient.
-
Vitamin B12 – essential for myelin; replacement only when low.
-
Folate (vitamin B9) – supports DNA repair and nerve health when deficient.
-
Vitamin B1 (thiamine) – deficiency can cause neuropathy; replacement corrects this.
-
Magnesium – may help cramps in some people, but strong evidence is limited.
-
Vitamin E – antioxidant, mainly important in known deficiency states.
-
Probiotic and fibre supplements – support gut health, which may indirectly help nutrient absorption and general wellbeing. ScienceDirect+1
(For each, dosing should be individualized based on blood tests and medical advice.)
Immunity-supporting, regenerative and stem-cell-related drugs
-
Standard vaccines (influenza, pneumococcal, COVID-19 and others)
These are not “booster drugs” in the commercial sense, but they are crucial immune-protecting tools. Vaccines help the immune system recognize infections early and can prevent pneumonia or severe viral illness, which could worsen weakness or cause prolonged bed rest. People with CMT2V should usually follow national vaccine schedules unless their doctor advises otherwise. Genetic Diseases Center+1 -
Vitamin D as an immune modulator
Vitamin D influences immune cell activity as well as bone health. Low levels are common and linked with poorer general health. Correcting deficiency with doctor-guided doses can support immune function, though it does not directly repair nerves. Blood levels are checked to avoid both deficiency and toxicity. PMC+1 -
Intravenous immunoglobulin (IVIG) – rarely, for overlapping immune neuropathies
IVIG is a pooled antibody product used for some autoimmune neuropathies, like CIDP. It is not a standard treatment for pure genetic CMT2V, but may be considered if doctors suspect an additional immune-mediated process. It modulates the immune system and can reduce damaging antibodies. It is expensive and has potential side effects, so is used only in selected cases. ScienceDirect+1 -
Experimental gene therapy vectors
Gene therapy aims to deliver a normal gene copy or silence a harmful one using viral vectors. Several gene-based strategies are in development for CMT1A and other neuropathies, but none are yet approved for CMT2V. These treatments are available only in research environments and require complex safety monitoring. PMC+2PMC+2 -
Experimental stem cell-based therapies
Researchers are studying stem cells that might support regrowth of myelin or axons, or release helpful growth factors. So far, there is no approved stem cell treatment for CMT2V, and commercial clinics offering “stem cell cures” outside clinical trials are considered unsafe and unproven. Patients should be very cautious and seek specialist advice. PMC+1 -
Neurotrophic factors and regenerative small molecules (research only)
Various growth factors and small molecules that protect axons or mitochondria are under study. Some aim to improve energy use inside nerve cells or reduce toxic protein build-up. At the moment, these agents are only used in clinical trials or animal models and should not be obtained from unregulated sources. PMC+2ScienceDirect+2
Surgeries
-
Soft-tissue surgery for tight tendons
Lengthening of the Achilles tendon or other tight tendons can improve ankle position, allow the heel to touch the ground, and make brace use easier. This is considered when severe tightness prevents normal standing or walking despite therapy and bracing. Medscape eMedicine+1 -
Foot deformity correction (for pes cavus or claw toes)
In long-standing CMT, unbalanced muscle pull can cause high-arched feet and clawed toes. Surgeons may move tendons, reshape bones, or fuse joints to create a flatter, more stable foot. The goal is to reduce pain, prevent ulcers and make walking safer with or without braces. Medscape eMedicine+2ScienceDirect+2 -
Osteotomy and joint fusion
Sometimes bones are cut and repositioned (osteotomy) or joints are fused to correct severe deformity that cannot be managed by soft-tissue surgery alone. Fusion sacrifices some movement to gain stability and relieve pain. Decisions are based on age, activity level and severity of deformity. Medscape eMedicine+1 -
Spinal surgery for scoliosis (if present)
Some people with CMT develop spinal curvature. If scoliosis becomes severe, causes pain or affects lung function, spinal fusion or other corrective surgery may be recommended. The aim is to prevent further curvature and protect breathing and sitting or standing alignment. Medscape eMedicine+1 -
Nerve decompression surgery (carefully selected cases)
If a specific nerve is compressed (for example, at the ankle or wrist) on top of the underlying neuropathy, decompression surgery may relieve extra pressure. However, because CMT already weakens nerves, results can be variable, and such surgery is only considered after thorough evaluation by experienced surgeons. Medscape eMedicine+1
Prevention and lifestyle measures
-
Protect feet daily: check for cuts, blisters, colour changes.
-
Wear well-fitting shoes and avoid walking barefoot, even at home.
-
Use braces, splints and aids as prescribed to prevent falls and deformities.
-
Keep a healthy weight to reduce pressure on weak legs and feet.
-
Avoid smoking and limit alcohol to protect nerves and blood vessels.
-
Stay active with safe, low-impact exercise most days of the week.
-
Practise good sleep habits and stress management to support coping.
-
Manage other health conditions (diabetes, high blood pressure, cholesterol).
-
Keep vaccinations up to date to avoid preventable infections.
-
Attend regular check-ups with neurologists, therapists and foot specialists. PMC+2ScienceDirect+2
When to see doctors
You should see a doctor (preferably a neurologist familiar with neuromuscular disease) if you notice new or worsening numbness, burning pain, cramps, weakness, balance problems, frequent falls, or foot deformity. A specialist can confirm the diagnosis, arrange genetic testing, and build a treatment plan with therapists and orthotists. Genetic Diseases Center+2Muscular Dystrophy Association+2
Urgent medical review is needed if you develop sudden rapid weakness, loss of ability to walk, bowel or bladder problems, severe back pain with leg weakness, high fever with spreading foot wounds, or thoughts of harming yourself. These signs may mean something more than CMT, such as infection or spinal cord disease, and must be treated quickly. PMC+2ScienceDirect+2
What to eat and what to avoid
-
Eat a balanced diet rich in vegetables, fruits, whole grains, lean proteins and healthy fats to support overall nerve and muscle health.
-
Choose foods high in omega-3 fats, such as fish, walnuts and flaxseeds, which may help reduce inflammation.
-
Include calcium and vitamin-D-rich foods (dairy, fortified plant milks, small fish with bones) to protect bones.
-
Drink enough water during the day to prevent cramps and constipation.
-
Limit sugary drinks and refined snacks to avoid weight gain and diabetes risk.
-
Avoid heavy alcohol intake, which can directly damage nerves.
-
Avoid smoking and second-hand smoke, as they harm circulation and healing.
-
Be cautious with “herbal nerve cures” sold online; many lack evidence and may interact with medicines.
-
If vegetarian or vegan, plan carefully with a dietitian to ensure enough B12, iron and protein.
-
Discuss any major diet change or supplement with your doctor or dietitian first. PMC+1
Frequently asked questions
-
Is CMT2V curable?
No. CMT2V is a lifelong, inherited condition. Current treatments cannot remove the genetic mutation or fully repair damaged nerves. However, with good supportive care, many people can slow complications, reduce pain and stay active in work or school for many years. Genetic Diseases Center+2PMC+2 -
Will everyone with CMT2V end up in a wheelchair?
Not everyone needs a wheelchair. Some people use braces, sticks or walkers only for longer distances, while others may eventually need a chair for safety and energy saving. The course is very variable. Early therapy, braces and lifestyle care can delay disability. Muscular Dystrophy Association+2PMC+2 -
Is CMT2V always painful?
Many people with CMT2V have leg pain, tingling or burning, but some have mainly numbness or weakness. Pain can often be managed with medicines, physical methods and lifestyle changes, even if it cannot be completely removed. Genetic Diseases Center+2Muscular Dystrophy Association+2 -
Can exercise make CMT2V worse?
Properly chosen, low-impact exercise usually helps, not harms. Over-hard or high-impact training can cause injury or fatigue. A physiotherapist can design a safe program that respects your limits and adjusts as you change. Physiopedia+2nhs.uk+2 -
Should I avoid pregnancy if I have CMT2V?
Many people with CMT have successful pregnancies. But there is a 50% chance of passing the mutation to each child in autosomal dominant disease. Genetic counselling can help you understand your personal risks and options before planning a family. Genetic Diseases Center+1 -
Can diet alone treat CMT2V?
No diet can change the underlying genetic problem. A healthy diet is still important to keep weight, bones and general health under control and to avoid extra stress on weak muscles and nerves. PMC+1 -
Is there any special vitamin that cures CMT?
No vitamin has been proven to cure CMT. Vitamins like B12 or vitamin D should be replaced only if blood tests show deficiency. Very high doses of some vitamins, such as B6, can actually damage nerves. The Lancet+2PMC+2 -
Are stem cell clinics on the internet safe for CMT?
Most commercial stem cell clinics offer unproven treatments without proper trials. They can be expensive and risky. At present, stem cell approaches for CMT are experimental and should only be received as part of approved clinical research. PMC+2ScienceDirect+2 -
Can I play sports if I have CMT2V?
Many people can enjoy low-impact sports like swimming, cycling, or modified games, especially with braces or supports. Contact or high-impact sports carry higher risk of falls or joint damage. Discuss your favourite activities with your therapist and doctor to adapt them safely. Physiopedia+2nhs.uk+2 -
Will surgery fix my CMT2V?
Surgery can correct deformities or relieve specific problems, such as severe foot arches or tendon tightness, but it does not correct the underlying nerve disease. Surgically improved alignment can still greatly improve comfort, walking and shoe fitting. Medscape eMedicine+1 -
Is CMT2V the same as CMT1 or other CMT types?
All CMT types share some features but differ in which part of the nerve is affected and which gene is mutated. CMT1 mainly affects myelin, while CMT2 forms, including CMT2V, mainly affect the axon. Management principles are similar, but research treatments may be type-specific. Muscular Dystrophy Association+2PMC+2 -
Can children show symptoms of CMT2V?
CMT2V can start at various ages, from childhood to older adulthood. Some people first notice clumsiness or frequent falls as a child, while others have normal childhood and develop symptoms later. Early assessment is helpful if there is a family history. Genetic Diseases Center+1 -
How often should I see my neurologist?
The exact schedule varies, but many people benefit from at least yearly reviews, and more often when symptoms are changing, new braces or medicines are needed, or surgery is being considered. Regular follow-up keeps the care plan up to date. Muscular Dystrophy Association+2PMC+2 -
Can I drive if I have CMT2V?
Many people can drive safely using automatic cars, hand controls, or adapted pedals. Assessment by a driving specialist or occupational therapist is sometimes recommended. If reaction time, leg strength or sensation are very poor, driving may become unsafe and alternatives should be considered. Muscular Dystrophy Association+1 -
Where can I find more support and information?
Patient organizations such as the CMT Research Foundation and other rare disease groups provide easy-to-read information, webinars, support groups and news about research. Your neurologist may also know local centres of excellence for neuromuscular disorders. Genetic Diseases Center+1
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.